申请人:Novartis AG
公开号:US20130225574A1
公开(公告)日:2013-08-29
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
本发明涉及氧唑烷-2-酮取代嘧啶化合物,其作为PI3K(磷脂酰肌醇-3-激酶)抑制剂,以及其药物组合物、制备方法和用于治疗依赖于PI3K的疾病、病症和疾病的用途。